当前位置:首页 - 行情中心 - 皓宸医疗(002622) - 财务分析 - 利润表

皓宸医疗

(002622)

  

流通市值:24.19亿  总市值:24.19亿
流通股本:8.40亿   总股本:8.40亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入142,937,780.75861,568,412.49635,030,298.87382,010,234.1
营业收入142,937,780.75861,568,412.49635,030,298.87382,010,234.1
二、营业总成本167,162,234.16856,749,904.93630,093,894.86398,227,590.97
营业成本87,899,813.34445,208,103.19330,407,017.3206,067,242.04
税金及附加556,699.052,642,248.221,971,996.361,228,304.73
销售费用32,459,362.47186,112,607.74141,873,589.2489,747,327.44
管理费用31,914,795.72166,984,424.07115,737,337.1274,914,155.33
研发费用4,192,860.4410,114,606.535,583,042.653,605,476.51
财务费用10,138,703.1445,687,915.1834,520,912.1922,665,084.92
其中:利息费用9,990,727.5642,875,298.8232,223,746.8121,454,310.59
其中:利息收入180,997.211,329,493.671,088,328.61897,501.49
加:投资收益3,296,969.24-3,704,345.8421,512,603.7716,737,122.44
资产处置收益25,778.45-576,307.24-1,486.97-
资产减值损失(新)-50--361,829.62-
信用减值损失(新)1,539,438.55-2,030,381.081,016,271.721,849,323.45
其他收益1,571,405.935,220,629.594,348,332.371,817,867.61
营业利润平衡项目0000
四、营业利润-17,790,911.243,728,102.9931,450,295.284,186,956.63
加:营业外收入127,384.612,394,058.19186,579.91165,728.27
减:营业外支出185,352.0415,409,196.37334,261.26166,708.68
利润总额平衡项目0000
五、利润总额-17,848,878.67-9,287,035.1931,302,613.934,185,976.22
减:所得税费用154,776.575,950,671.482,620,935.631,379,875.03
六、净利润-18,003,655.24-15,237,706.6728,681,678.32,806,101.19
持续经营净利润-18,003,655.24-15,237,706.6728,681,678.32,806,101.19
归属于母公司股东的净利润-12,214,580.55-37,690,897.8113,496,659.38553,485.18
少数股东损益-5,789,074.6922,453,191.1415,185,018.922,252,616.01
(一)基本每股收益-0.01-0.040.020
(二)稀释每股收益-0.01-0.040.020
八、其他综合收益-3,764,533.942,942,040.891,540,094.912,010,575.34
归属于母公司股东的其他综合收益-3,764,533.942,942,040.891,540,094.912,010,575.34
九、综合收益总额-21,768,189.18-12,295,665.7830,221,773.214,816,676.53
归属于母公司股东的综合收益总额-15,979,114.49-34,748,856.9215,036,754.292,564,060.52
归属于少数股东的综合收益总额-5,789,074.6922,453,191.1415,185,018.922,252,616.01
公告日期2025-04-262025-04-262024-10-312024-08-30
审计意见(境内)带强调事项段的无保留意见
TOP↑